Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CALASPARGASE PEGOL-MKNL: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

45.5%
Female
54.5%
Male

Age Information

The average age of patients reporting adverse events with CALASPARGASE PEGOL-MKNL is 13.2 years.

Geographic Distribution

The majority of adverse event reports for CALASPARGASE PEGOL-MKNL originate from US.

Report Summary & Outcomes

505
Total Reports
505
As Primary/Secondary Suspect
30
Deaths Reported
200
Hospitalizations
58
Life-Threatening
4
Disabilities

Reporting Timeline

First adverse event report: 20220110. Most recent report: 20250918. View full timeline →

More About CALASPARGASE PEGOL-MKNL

CALASPARGASE PEGOL-MKNL Full Profile Reports by Year Drug Interactions